Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
Sikai Ling(Shanghai Jiao Tong University), Yujia Cai(Shanghai Jiao Tong University)
Cited by 63
Related Papers
Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
|Nature Biotechnology|2021|178
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers
|Nature Biomedical Engineering|2024|89
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
|Cell stem cell|2024|77
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10
Immunostimulatory guide RNAs mediate potent antiviral response
|bioRxiv (Cold Spring Harbor Laboratory)|2018|2